A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study
Titel:
A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study
Auteur:
Kupczyk, Maciej Majak, Paweł Kuna, Piotr Asankowicz-Bargiel, Beata Barańska, Eliza Dobek, Rafał Garbicz, Sławomir Jerzyńska, Joanna Latos, Anna Machowiak, Wojciech Majorek-Olechowska, Bernadetta Olech-Cudzik, Anna Poziomkowska-Gęsicka, Iwona Rulewicz-Warniełło, Mirosława Świderska, Anna Tarnowski, Michał Kopyto, Przemysław